| 1 |
35977101 |
10.1182/blood.2022016056 |
2022 |
Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma. |
KDR |
| 2 |
32997825 |
10.1111/ejh.13526 |
2021 |
VEGFR2 and VEGFA polymorphisms are not associated with an inferior prognosis in Caucasian patients with aggressive B-cell lymphoma. |
KDR |
| 3 |
33410241 |
10.1111/cas.14801 |
2021 |
VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers. |
KDR |
| 4 |
34219681 |
10.3233/TUB-211510 |
2021 |
Angiogenesis' related genetic variants alter clinical features and prognosis of diffuse large B-cell lymphoma patients. |
KDR |
| 5 |
34471499 |
10.1016/j.csbj.2021.08.003 |
2021 |
A data-driven methodology towards evaluating the potential of drug repurposing hypotheses. |
KDR |
| 6 |
32158186 |
10.2147/DDDT.S227477 |
2020 |
Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study. |
KDR |
| 7 |
32565964 |
10.3892/ol.2020.11552 |
2020 |
Comprehensive characterization of driver genes in diffuse large B cell lymphoma. |
KDR |
| 8 |
30423319 |
10.1016/j.ejphar.2018.11.012 |
2019 |
Apatinib exerts anti-tumor activity to non-Hodgkin lymphoma by inhibition of the Ras pathway. |
KDR |
| 9 |
30896872 |
10.3892/mmr.2019.10074 |
2019 |
Umbilical cord blood‑derived Helios‑positive regulatory T cells promote angiogenesis in acute lymphoblastic leukemia in mice via CCL22 and the VEGFA‑VEGFR2 pathway. |
KDR |
| 10 |
31126146 |
10.3390/cells8050498 |
2019 |
c-Cbl: An Important Regulator and a Target in Angiogenesis and Tumorigenesis. |
KDR |
| 11 |
31211886 |
10.1111/ejh.13279 |
2019 |
Bevacizumab synergises with the BCL 2 inhibitor venetoclax to effectively treat B-cell non-Hodgkin's lymphoma. |
KDR |
| 12 |
29345176 |
10.1080/10428194.2017.1422858 |
2018 |
Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival. |
KDR |
| 13 |
29455107 |
10.1016/j.leukres.2018.02.007 |
2018 |
Helios expression in regulatory T cells promotes immunosuppression, angiogenesis and the growth of leukemia cells in pediatric acute lymphoblastic leukemia. |
KDR |
| 14 |
29588308 |
10.1158/1078-0432.CCR-18-0103 |
2018 |
Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic Therapies. |
KDR |
| 15 |
29636358 |
10.1158/1078-0432.CCR-17-2452 |
2018 |
Resistance Mechanisms to Targeted Therapies in <i>ROS1</i><sup>+</sup> and <i>ALK</i><sup>+</sup> Non-small Cell Lung Cancer. |
KDR |
| 16 |
29854308 |
10.18632/oncotarget.25209 |
2018 |
Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel. |
KDR |
| 17 |
29864401 |
10.1016/j.yexcr.2018.05.038 |
2018 |
CS2164 exerts an antitumor effect against human Non-Hodgkin's lymphomas in vitro and in vivo. |
KDR |
| 18 |
30005850 |
10.1016/j.cancergen.2018.04.119 |
2018 |
Challenges in next generation sequencing analysis of somatic mutations in transplant patients. |
KDR |
| 19 |
30074936 |
10.1097/CAD.0000000000000667 |
2018 |
Apatinib reverses alectinib resistance by targeting vascular endothelial growth factor receptor 2 and attenuating the oncogenic signaling pathway in echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion gene-positive lung cancer cell lines. |
KDR |
| 20 |
30144594 |
10.1016/j.wneu.2018.08.080 |
2018 |
Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling. |
KDR |
| 21 |
27774879 |
10.2174/1570163813666161019143740 |
2017 |
Strong Anti-tumorous Potential of Nardostachys jatamansi Rhizome Extract on Glioblastoma and In Silico Analysis of its Molecular Drug Targets. |
KDR |
| 22 |
26879230 |
10.1161/CIRCRESAHA.115.307679 |
2016 |
Selective Targeting of a Novel Epsin-VEGFR2 Interaction Promotes VEGF-Mediated Angiogenesis. |
KDR |
| 23 |
26970956 |
10.1186/s40792-016-0152-7 |
2016 |
Dynamic computed tomography findings of an accessory spleen in the pelvis: a case report. |
KDR |
| 24 |
27365461 |
10.3324/haematol.2015.135475 |
2016 |
Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene. |
KDR |
| 25 |
27806094 |
10.1371/journal.pone.0165876 |
2016 |
EGF-Induced VEGF Exerts a PI3K-Dependent Positive Feedback on ERK and AKT through VEGFR2 in Hematological In Vitro Models. |
KDR |
| 26 |
25329007 |
10.3109/10428194.2014.977886 |
2015 |
A phase II study of AZD2171 (cediranib) in the treatment of patients with acute myeloid leukemia or high-risk myelodysplastic syndrome. |
KDR |
| 27 |
25444907 |
10.1016/j.canlet.2014.11.024 |
2015 |
Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer. |
KDR |
| 28 |
25689789 |
10.1016/j.bbmt.2014.12.027 |
2015 |
Content of endothelial progenitor cells in autologous stem cell grafts predict survival after transplantation for multiple myeloma. |
KDR |
| 29 |
25951043 |
10.1080/15548627.2015.1017192 |
2015 |
The role of STAT3 in autophagy. |
KDR |
| 30 |
23772669 |
10.3109/10428194.2013.813629 |
2014 |
Prognostic significance of immunohistochemical expression of the angiogenic molecules vascular endothelial growth factor-A, vascular endothelial growth factor receptor-1 and vascular endothelial growth factor receptor-2 in patients with classical Hodgkin lymphoma. |
KDR |
| 31 |
25233367 |
10.1021/ci500414b |
2014 |
Assessing an ensemble docking-based virtual screening strategy for kinase targets by considering protein flexibility. |
KDR |
| 32 |
25289059 |
10.3892/etm.2014.1930 |
2014 |
Effect of a heat shock protein 90-specific inhibitor on the proliferation and apoptosis induced by VEGF-C in cervical cancer cells. |
KDR |
| 33 |
23624620 |
10.2340/00015555-1589 |
2013 |
Microvessel density and expression of vascular endothelial growth factor and its receptors in different subtypes of primary cutaneous B-cell lymphoma. |
KDR |
| 34 |
23991993 |
10.7314/apjcp.2013.14.7.4301 |
2013 |
B-cell Lymphoma 2 rs17757541 C>G polymorphism was associated with an increased risk of gastric cardiac adenocarcinoma in a Chinese population. |
KDR |
| 35 |
22129133 |
10.1111/j.1349-7006.2011.02168.x |
2012 |
VEGFA and VEGFR2 genetic polymorphisms and survival in patients with diffuse large B cell lymphoma. |
KDR |
| 36 |
22251800 |
10.1186/1471-2407-12-19 |
2012 |
DNA methylation regulates expression of VEGF-R2 (KDR) and VEGF-R3 (FLT4). |
KDR |
| 37 |
19211267 |
10.1016/j.carpath.2008.11.001 |
2010 |
Atrial fibrillation is associated with cardiac hypoxia. |
KDR |
| 38 |
19120365 |
10.1111/j.1365-2141.2008.07534.x |
2009 |
Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma. |
KDR |
| 39 |
19419943 |
10.2478/v10042-009-0004-4 |
2009 |
Soluble angiogenesis markers in gastric tumor patients. |
KDR |
| 40 |
19701853 |
10.1080/10428190903156729 |
2009 |
Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas. |
KDR |
| 41 |
19707156 |
10.1097/MPH.0b013e3181b258df |
2009 |
Expression of VEGF and VEGF receptors in childhood precursor B-cell acute lymphoblastic leukemia evaluated by immunohistochemistry. |
KDR |
| 42 |
19860625 |
10.3109/10428190903275586 |
2009 |
Lysophosphatidic acid receptor expression in chronic lymphocytic leukemia leads to cell survival mediated though vascular endothelial growth factor expression. |
KDR |
| 43 |
20011623 |
10.1007/s12195-009-0069-3 |
2009 |
Shear Stress Regulates the Flk-1/Cbl/PI3K/NF-κB Pathway Via Actin and Tyrosine Kinases. |
KDR |
| 44 |
18461646 |
10.1002/hon.861 |
2008 |
Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation. |
KDR |
| 45 |
19021062 |
10.1080/10428190802450629 |
2008 |
Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins. |
KDR |
| 46 |
17372230 |
10.1073/pnas.0700809104 |
2007 |
A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCgamma1 activation and angiogenesis. |
KDR |
| 47 |
17488657 |
10.3324/haematol.10723 |
2007 |
Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients. |
KDR |
| 48 |
17577783 |
10.1080/10428190701340616 |
2007 |
Coordinated deregulation of cellular receptors, proangiogenic factors and intracellular pathways in acute myeloid leukaemia. |
KDR |
| 49 |
17917967 |
10.1080/10428190701534424 |
2007 |
Myeloid leukemias express a broad spectrum of VEGF receptors including neuropilin-1 (NRP-1) and NRP-2. |
KDR |
| 50 |
17169805 |
10.1080/10428190600948253 |
2006 |
Downregulation of VEGF-A, STAT5 and AKT in acute myeloid leukemia blasts of patients treated with SU5416. |
KDR |
| 51 |
17169806 |
10.1080/10428190600948048 |
2006 |
The investigation of mutation and single nucleotide polymorphism of receptor tyrosine kinases and downstream scaffold molecules in acute myeloid leukemia. |
KDR |
| 52 |
15693894 |
10.1111/j.1365-2559.2005.02081.x |
2005 |
The expression and cellular localization of phosphorylated VEGFR2 in lymphoma and non-neoplastic lymphadenopathy: an immunohistochemical study. |
KDR |
| 53 |
16305489 |
10.2174/156652405774641106 |
2005 |
Kinases as drug discovery targets in hematologic malignancies. |
KDR |
| 54 |
16383242 |
|
2005 |
[Preliminary study of VEGF and its receptor expression on childhood acute lymphoblastic leukemia and its relativity to clinical manifestations]. |
KDR |
| 55 |
14654077 |
10.1016/s0145-2126(03)00188-7 |
2004 |
Immature B cell malignancies synthesize VEGF, VEGFR-1 (Flt-1) and VEGFR-2 (KDR). |
KDR |
| 56 |
14996703 |
10.1182/blood-2003-08-2763 |
2004 |
VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. |
KDR |
| 57 |
15223651 |
10.1080/10428190410001712225 |
2004 |
Inhibition of both the autocrine and the paracrine growth of human leukemia with a fully human antibody directed against vascular endothelial growth factor receptor 2. |
KDR |
| 58 |
15634546 |
|
2004 |
[Dynamic observation of vascular endothelial growth factor (VEGF)/VEGF-receptors expression in acute leukemia]. |
KDR |
| 59 |
12607599 |
10.1097/00129039-200212000-00005 |
2002 |
Immunohistochemical expression of basic fibroblast growth factor, vascular endothelial growth factor, and their receptors in stage IV non-Hodgkin lymphoma. |
KDR |
| 60 |
11378536 |
10.3109/10428190109057978 |
2001 |
Vascular endothelial growth factor/vascular permeability factor in the pathogenesis of primary effusion lymphomas. |
KDR |
| 61 |
10623771 |
10.1128/jvi.74.2.1038-1044.2000 |
2000 |
The human herpesvirus 8 homolog of Epstein-Barr virus SM protein (KS-SM) is a posttranscriptional activator of gene expression. |
KDR |
| 62 |
10905767 |
10.1016/s1083-8791(00)70055-3 |
2000 |
Donor origin of circulating endothelial progenitors after allogeneic bone marrow transplantation. |
KDR |
| 63 |
9973224 |
|
1999 |
Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. |
KDR |
Datasets
Models
